Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?

BACKGROUND: The increasing use of erythropoietins with long half-lives and the tendency to lengthen the administration interval to monthly injections call for raising awareness on the pharmacokinetics and risks of new erythropoietin stimulating agents (ESA). Their pharmacodynamic complexity and indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabutti, Luca, Nobile, Filippo, Forni, Valentina, Rigamonti, Fabio, Weibel, Nadir, Burnier, Michel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055807/
https://www.ncbi.nlm.nih.gov/pubmed/21332992
http://dx.doi.org/10.1186/1471-2369-12-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055807/
https://www.ncbi.nlm.nih.gov/pubmed/21332992
http://dx.doi.org/10.1186/1471-2369-12-11

Ejemplares similares